Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes

Atherosclerosis

Volumn 227, Issue 1, 2013, Pages 140-146

  Yiu, Yuen Fung ^a   Yiu, Kai Hang ^a   Siu, Chung Wah ^a   Chan, Yap Hang ^a   Li, Sheung Wai ^a   Wong, Lai Yung ^a   Lee, Stephen W L ^b   Tam, Sidney ^c   Wong, Eric W K ^c   Lau, Chu Pak ^a   Cheung, Bernard M Y ^a   Tse, Hung Fat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b TUNG WAH HOSPITAL   (Hong Kong)

^c QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Endothelial function; Type 2 diabetes mellitus; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 8 ISOPROSTANE; C REACTIVE PROTEIN; CALCIUM ION; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PLACEBO; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; VITAMIN D;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DILATATION; DOUBLE BLIND PROCEDURE; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM; FEMALE; FLOW MEDIATED DILATATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

AGED; BIOLOGICAL MARKERS; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CALCIUM; CHOLECALCIFEROL; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULSE WAVE ANALYSIS; VASODILATION; VITAMIN D;

EID: 84873473168     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.12.013     Document Type: Article

References (37)

1. Lee J.H., O'Keefe J.H., Bell D., Hensrud D.D., Holick M.F. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol 2008, 52:1949-1956.
2. Wang L., Manson J.E., Song Y., Sesso H.D. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010, 152:315-323.
3. Dobnig H., Pilz S., Scharnagl H., et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008, 168:1340-1349.
4. Giovannucci E., Liu Y., Hollis B.W., Rimm E.B. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008, 168:1174-1180.
5. Forman J.P., Giovannucci E., Holmes M.D., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007, 49:1063-1069.
6. Lu L., Yu Z., Pan A., et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009, 32:1278-1283.
7. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
8. Seamans K.M., Cashman K.D. Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr 2009, 89:1997S-2008S.
9. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84:18-28.
10. Yeboah J., Folsom A.R., Burke G.L., et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009, 120:502-509.
11. Kim J.A., Montagnani M., Koh K.K., Quon M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006, 113:1888-1904.
12. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600.
13. Yiu Y.F., Chan Y.H., Yiu K.H., et al. Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J Clin Endocrinol Metab 2011, 96:E830-E835.
14. Sugden J.A., Davies J.I., Witham M.D., Morris A.D., Struthers A.D. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008, 25:320-325.
15. Witham M.D., Dove F.J., Dryburgh M., Sugden J.A., Morris A.D., Struthers A.D. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2010, 53:2112-2119.
16. Harris R.A., Pedersen-White J., Guo D.H., et al. Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 2011, 24:557-562.
17. 2003 report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl. 1):S5-20.
18. Hathcock J.N., Shao A., Vieth R., Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007, 85:6-18.
19. Chan Y.H., Lau K.K., Yiu K.H., et al. Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke. Eur Heart J 2008, 29:2800-2807.
20. Luk T.H., Dai Y.L., Siu C.W., et al. Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: a randomized controlled trial. Eur J Cardiovasc Prev Rehabil 2012, 19:830-839.
21. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 2002, 39:257-265.
22. Santos-Garcia D., Blanco M., Serena J., et al. Brachial arterial flow mediated dilation in acute ischemic stroke. Eur J Neurol 2009, 16:684-690.
23. Yiu K.H., Yeung C.K., Chan H.T., et al. Increased arterial stiffness in patients with psoriasis is associated with active systemic inflammation. Br J Dermatol 2011, 164:514-520.
24. Talmor Y., Golan E., Benchetrit S., et al. Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Ren Physiol 2008, 294:F1059-F1064.
25. 2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009, 120:687-698.
26. Kosch M., Hausberg M., Vormbrock K., et al. Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res 2000, 47:813-818.
27. Diamond T., Wong Y.K., Golombick T. Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency. Osteoporos Int 2012 Mar 16, [Epub ahead of print].
28. Elamin M.B., Abu Elnour N.O., Elamin K.B., et al. Vitamin d and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011, 96:1931-1942.
29. Rubin M.R., Maurer M.S., McMahon D.J., Bilezikian J.P., Silverberg S.J. Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2005, 90:3326-3330.
30. Schillaci G., Pucci G., Pirro M., et al. Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis 2011, 218:96-101.
31. Lavie C.J., Lee J.H., Milani R.V. Vitamin D and cardiovascular disease will it live up to its hype?. J Am Coll Cardiol 2011, 58:1547-1556.
32. Kestenbaum B., Katz R., de Boer I., et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 2011, 58:1433-1441.
33. Fichtlscherer S., Rosenberger G., Walter D.H., Breuer S., Dimmeler S., Zeiher A.M. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000, 102:1000-1006.
34. Sattar N., Murray H.M., McConnachie A., et al. C-reactive protein and prediction of coronary heart disease and global vascular events in the prospective study of pravastatin in the elderly at risk (PROSPER). Circulation 2007, 115:981-989.
35. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347:1557-1565.
36. Giulietti A., van Etten E., Overbergh L., Stoffels K., Bouillon R., Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 2007, 77:47-57.
37. von Hurst P.R., Stonehouse W., Coad J. Vitamin D supplementation reduces insulin resistance in south Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr 2010, 103:549-555.